UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?

Cancer, 2019-09, Vol.125 (18), p.3172-3183

2019

Link zum Volltext

Verfügbarkeit prüfen

Salpingectomy and Ovarian Cancer Prevention-Reply

JAMA surgery, 2024-04, Vol.159 (4), p.470

2024

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract

Case reports in oncological medicine, 2019, Vol.2019, p.4189275-5

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1389-1397

2020

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Cancer, 2023-07, Vol.129 (13), p.2004-2012

2023

Link zum Volltext

Verfügbarkeit prüfen

Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review

JAMA surgery, 2023-11, Vol.158 (11), p.1204

2023

Link zum Volltext

Verfügbarkeit prüfen

Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?

International journal of gynecological cancer, 2024-03, Vol.34 (3), p.379-385

2024

Link zum Volltext

Verfügbarkeit prüfen

Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State

Gynecologic oncology, 2024-03, Vol.182, p.141-147

2024

Link zum Volltext

Verfügbarkeit prüfen

Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs

Familial cancer, 2024-06, Vol.23 (2), p.111-120

2024

Link zum Volltext

Verfügbarkeit prüfen

Uterine rhabdomyosarcoma in adults

Human pathology, 2018-04, Vol.74, p.122-128

2018

Link zum Volltext

Verfügbarkeit prüfen

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

Gynecologic oncology, 2023-03, Vol.170, p.46-53

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination

Cancer Immunology, Immunotherapy, 2023, Vol.72 (1), p.183-191

2023

Link zum Volltext

Verfügbarkeit prüfen

A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study

International journal of gynecological cancer, 2024-07, Vol.34 (7), p.1051-1059

2024

Link zum Volltext

Verfügbarkeit prüfen

Cardiophrenic lymph nodes in advanced ovarian cancer

International journal of gynecological cancer, 2023-12, Vol.34 (1), p.150-158

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic features of endometrial cancer with mismatch repair deficiency

Ecancermedicalscience, 2020-06, Vol.14, p.1061-1061

2020

Link zum Volltext

Verfügbarkeit prüfen

Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management

Ecancermedicalscience, 2020-05, Vol.14, p.1043

2020

Link zum Volltext

Verfügbarkeit prüfen

Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis

JCO clinical cancer informatics, 2021-06, Vol.5, p.775

2021

Link zum Volltext

Verfügbarkeit prüfen

LONG-TERM OUTCOMES OF PATIENTS WITH RECURRENT OVARIAN CANCER TREATED WITH A POLYVALENT VACCINE WITH BEVACIZUMAB COMBINATION

Cancer immunology, immunotherapy : CII, 2022-07, Vol.72 (1), p.183-191

2022

Link zum Volltext

Verfügbarkeit prüfen

Distinguishing primary mucinous ovarian tumors from metastases of non-gynecologic mucinous cancers: Can we leverage next-generation sequencing?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5582-5582

2023

Link zum Volltext

Verfügbarkeit prüfen

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5543-5543

2023

Link zum Volltext

Verfügbarkeit prüfen

Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5565-5565

2023

Link zum Volltext

Verfügbarkeit prüfen

Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?

Familial cancer, 2023-04, Vol.22 (2), p.127-133

2023

Link zum Volltext

Verfügbarkeit prüfen

Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management

Ecancermedicalscience, 2020, Vol.14, p.1043-1043

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(162)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(110)
Humans
(79)
Female
(55)
Male
(47)
Middle Aged
(32)
Adult
(26)
Risk Factors
(22)
Oncology
(21)
Adolescent
(20)
Aged
(20)
Public, Environmental & Occupational Health
(19)
Hiv
(18)
South Africa - Epidemiology
(17)
South Africa
(16)
Human Immunodeficiency Virus
(15)
Patients
(15)
Social Sciences
(15)
Young Adult
(15)
Diabetes
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?

Salpingectomy and Ovarian Cancer Prevention-Reply

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract

Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review

Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?

Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State

Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs

Uterine rhabdomyosarcoma in adults

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination

A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study

Cardiophrenic lymph nodes in advanced ovarian cancer

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Clinicopathologic features of endometrial cancer with mismatch repair deficiency

Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management

Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer

LONG-TERM OUTCOMES OF PATIENTS WITH RECURRENT OVARIAN CANCER TREATED WITH A POLYVALENT VACCINE WITH BEVACIZUMAB COMBINATION

Distinguishing primary mucinous ovarian tumors from metastases of non-gynecologic mucinous cancers: Can we leverage next-generation sequencing?

The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?

Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival

Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?

Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management

Suchergebnisse filtern